Search

everythinglearnresearchcommunity

for

Search:↓

Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.

Rural South Florida faces challenges in accessing dermatologic care, with many patients not attending specialist appointments.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Early recognition and treatment of tinea capitis are crucial to prevent severe scalp issues and prolonged therapy.

Cathelicidins could treat skin issues but face challenges like safety and resistance.

Cattle in Mymensingh, Bangladesh, face high parasitic disease rates, needing better deworming and management.

Leukemia should be considered in teens with unexplained bleeding.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Men have more severe COVID-19 outcomes than women.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.

COVID-19 may harm male fertility and damage the reproductive system.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

COVID-19 can harm many body parts, not just the lungs.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Wnt4 is essential for heart repair and could be a target for heart disease treatment.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.